Your browser doesn't support javascript.
loading
Association Between AZD7442 (Tixagevimab-Cilgavimab) Administration and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Hospitalization, and Mortality.
Kertes, Jennifer; Shapiro Ben David, Shirley; Engel-Zohar, Noya; Rosen, Keren; Hemo, Beatriz; Kantor, Avner; Adler, Limor; Shamir Stein, Naama; Mizrahi Reuveni, Miri; Shahar, Arnon.
Afiliação
  • Kertes J; Department of Health Evaluation and Research, Maccabi HealthCare Services, Tel Aviv-Jaffa, Israel.
  • Shapiro Ben David S; Division of Health, Maccabi HealthCare Services, Tel Aviv-Jaffa, Israel.
  • Engel-Zohar N; Sackler Faculty of Medicine, Department of Family Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Rosen K; Division of Data and Digital Health, Maccabi HealthCare Services, Tel Aviv-Jaffa, Israel.
  • Hemo B; Department of Health Evaluation and Research, Maccabi HealthCare Services, Tel Aviv-Jaffa, Israel.
  • Kantor A; Sackler Faculty of Medicine, Department of Family Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Adler L; Department of Health Evaluation and Research, Maccabi HealthCare Services, Tel Aviv-Jaffa, Israel.
  • Shamir Stein N; Department of Health Evaluation and Research, Maccabi HealthCare Services, Tel Aviv-Jaffa, Israel.
  • Mizrahi Reuveni M; Department of Health Evaluation and Research, Maccabi HealthCare Services, Tel Aviv-Jaffa, Israel.
  • Shahar A; Sackler Faculty of Medicine, Department of Family Medicine, Tel Aviv University, Tel Aviv, Israel.
Clin Infect Dis ; 76(3): e126-e132, 2023 02 08.
Article em En | MEDLINE | ID: mdl-35904210

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article